Semaphorin3A elevates vascular permeability and contributes to cerebral ischemia-induced brain damage : Scientific Reports : Nature Publishing Group | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« The #1 reason people die early, in each country

Atherosclerotic plaque characteristics identified by coronary CTA predicted lesion ischemia | Cardiology »

Semaphorin3A elevates vascular permeability and contributes to cerebral ischemia-induced brain damage : Scientific Reports : Nature Publishing Group

January 30, 2015 by 2012pharmaceutical

Semaphorin3A elevates vascular permeability and contributes to cerebral ischemia-induced brain damage : Scientific Reports : Nature Publishing Group

Reporter: Aviva Lev-Ari, PhD, RN

Semaphorin 3A (Sema3A) increased significantly in mouse brain following cerebral ischemia. However, the role of Sema3A in stroke brain remains unknown.

Source: www.nature.com

See on Scoop.it – Cardiovascular Disease: PHARMACO-THERAPY

Posted in Cerebrovascular and Neurodegenerative Diseases, Stroke | Leave a Comment

Leave a Reply Cancel reply

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Email Address

Join 1,254 other subscribers
Recent Posts
- 2022 FDA Drug Approval List, 2022 Biological Approvals and Approved Cellular and Gene Therapy Products January 17, 2023
- Verily announced other organizational changes, 1/13/2023 January 16, 2023
- Mission 4: Use of Systems Biology for Design of inhibitor of Galectins as Cancer Therapeutic – Strategy and Software December 13, 2022
- Science Has A Systemic Problem, Not an Innovation Problem December 12, 2022
- Chemistry Nobelist Carolyn Bertozzi’s years at UC Berkeley October 24, 2022
- Technion #1 in Europe in Field of AI for 2nd Straight Year October 20, 2022
- Endoglin Protein Interactome Profiling Identifies TRIM21 and Galectin-3 as New Binding Partners October 11, 2022
- The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells October 11, 2022
- Cancer Policy Related News from Washington DC and New NCI Appointments October 4, 2022
- Accelerating PROTAC drug discovery: Establishing a relationship between ubiquitination and target protein degradation October 4, 2022
Archives
Archives
Categories
Categories
Meta

%d bloggers like this: